Loading...
Loading...
- Guggenheim cut Biogen Inc BIIB price target from $410 to $325. Biogen shares closed at $321.17 on Thursday.
- Berenberg cut the price target for Qualys Inc QLYS from $96 to $82. Qualys shares closed at $84.34 on Thursday.
- B. Riley FBR lifted the price target on Acacia Communications, Inc. ACIA from $45 to $50.50. Acacia Communications shares closed at $47.17 on Thursday.
- UBS cut the price target for Kraft Heinz Co KHC from $55 to $39. Kraft Heinz shares closed at $48.18 on Thursday.
- Guggenheim lowered the price target for Regeneron Pharmaceuticals Inc REGN from $466 to $425. Regeneron Pharmaceuticals shares closed at $418.62 on Thursday.
- RBC Capital lowered the price target for Immune Design Corp IMDZ from $9 to $6. Immune Design shares closed at $5.82 on Thursday.
- Jefferies raised Citigroup Inc C price target from $64 to $73. Citigroup shares closed at $64.32 on Thursday.
- Sidoti & Co. cut the price target for Anika Therapeutics Inc ANIK from $56 to $41. Anika Therapeutics shares closed at $40.49 on Thursday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in